Veteran immunologist and former Pfizer R&D leader joins Circurna to advance its circular RNA therapeutic platform ...
Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...
News-Medical.Net on MSN
Non-coding RNA mutations unveiled as new cause of retinitis pigmentosa
Retinitis pigmentosa (RP) is a genetic eye disorder affecting around one in 5,000 people worldwide. It typically begins with ...
The investment will expand RNA T&T's operations and allow partners of both companies to leverage combined expertise in RNA-LNP therapeutics.
News-Medical.Net on MSN
RNA gene mutations identified as cause of inherited blindness
Researchers from Radboud university medical center and University of Basel have discovered new genetic causes of inherited ...
Advancing RNA therapeutics depends on understanding two critical questions: Where do drug candidates go, and what do they do ...
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
AZoLifeSciences on MSN
Synthetic RNA platform converts viral replication into detectable cellular signals
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
A giant impact on the early Earth could have brought the building blocks of RNA to our planet, which new research suggests ...
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...
In an investigation to find out what sparked life on Earth, researchers have discovered that RNA formed through surprisingly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback